Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PRAX
PRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRAX News
Affinity Asset Advisors Initiates Position in PRAX with 185,000 Shares
1d ago
NASDAQ.COM
Affinity Asset Advisors Acquires New Stake in Praxis Precision Medicines
1d ago
Fool
Soleus Capital Increases Stake in Celcuity
2d ago
Fool
Praxis Precision Medicines to Report Q4 and Full Year 2025 Financial Results
5d ago
Yahoo Finance
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 13 2026
Globenewswire
Praxis Grants 434 Restricted Stock Units to Attract New Employees
Jan 09 2026
Globenewswire
Praxis Grants 434 Restricted Stock Units to New Employees Under 2024 Inducement Plan
Jan 09 2026
Yahoo Finance
Praxis Appoints New Board Members and Promotes Executives to Enhance Growth Strategy
Jan 08 2026
Globenewswire
Bright Minds Biosciences Launches $100 Million Public Offering
Jan 07 2026
Benzinga
Praxis Precision Medicines Prices Underwritten Public Offering, Amount Undisclosed
Jan 07 2026
Yahoo Finance
Praxis Precision Medicines Prices 2.21M Share Offering at $260, Raising Approximately $575M
Jan 07 2026
NASDAQ.COM
Praxis Precision Medicines Prices 2.21M Share Offering at $260 Each
Jan 07 2026
Globenewswire
XBI Price Fluctuation Analysis: 52-Week High at $126.50
Jan 06 2026
NASDAQ.COM
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation, Stock Rises 13%
Dec 30 2025
NASDAQ.COM
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation, Stock Rises 13.25%
Dec 30 2025
Fool
US Stocks Close Lower on Monday, Led by Declines in Tech Sector
Dec 30 2025
NASDAQ.COM
Show More News
